MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

GlycoMimetics Company Profile (NASDAQ:GLYC)

Consensus Ratings for GlycoMimetics (NASDAQ:GLYC) (?)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.33 (74.06% upside)

Analysts' Ratings History for GlycoMimetics (NASDAQ:GLYC)
Show:
DateFirmActionRatingPrice TargetActions
6/5/2015Jefferies GroupReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Jefferies GroupReiterated RatingBuy -> Buy$18.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Canaccord GenuitySet Price TargetBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Stifel NicolausBoost Price TargetBuy$13.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/25/2015Canaccord GenuityReiterated RatingBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2014Stifel NicolausBoost Price TargetBuy$14.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2014Jefferies GroupBoost Price Target$13.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014BarclaysInitiated CoverageOverweight$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Canaccord GenuityInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Stifel NicolausInitiated CoverageBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2014Jefferies GroupInitiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha